ArticleEye (London, England)2026
Age, sex, and regional disparities in vision impairment burden among the population with diabetes: a 10-year trend analysis in Taiwan.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes prevalence is increasing in Taiwan, raising concern over vision impairment among affected individuals. This study aimed to assess the burden of cause-specific vision impairment among individuals with diabetes, overall and stratified by age, sex, geographic region, and time, with a particular focus on diabetic retinopathy (DR).
methodsA cross-sectional, annual analysis was conducted from 2010 to 2020. Population prevalence of major eye diseases among adults aged ≥20 years with diabetes was obtained from the National Health Insurance Research Database. Ophthalmological data from a multicentre electronic medical record system across various hospital levels were used to characterise cause-specific vision impairment. Hierarchical Bayesian models integrated these datasets to estimate the prevalence of vision impairment and corresponding years lived with disability.
resultsIn 2019, DR accounted for 1283.9 years lived with disability (95% credible interval: 992.9-1, 644.6), comprising 50.8% of the total vision impairment burden among individuals with diabetes, followed by glaucoma (11.7%) and cataract (9.9%). The age-standardised prevalence per 1000 individuals for DR-related vision impairment was 0.58 (0.43-0.76), 0.50 (0.36-0.67), 0.12 (0.06-0.20), and 0.09 (0.05-0.17) for mild, moderate, severe, and blindness, respectively. Higher burdens were observed in females, individuals aged 20-39, and residents of eastern Taiwan. Between 2010 and 2020, the prevalence of DR-related vision impairment decreased in the 55-69 age group and increased in the 20-39 age group.
conclusionsThis study highlights high-risk subgroups for vision impairment among individuals with diabetes, providing evidence to inform targeted public health and diabetes eye-care strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.